MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
VRCA Verrica Pharmaceuticals
- 0.694
- +0.018+2.65%
Close Dec 20 16:00 ET
- 0.700
- +0.006+0.84%
Pre 05:06 ET
62.87MMarket Cap-0.38P/E (TTM)
0.738High0.648Low1.54MVolume0.680Open0.676Pre Close1.07MTurnover3.56%Turnover RatioLossP/E (Static)90.56MShares11.41052wk High-1.85P/B29.94MFloat Cap0.61152wk Low--Dividend TTM43.13MShs Float23.290Historical High--Div YieldTTM13.29%Amplitude0.611Historical Low0.696Avg Price1Lot Size
Verrica Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -161.06%-1.78M | 2,744.51%5.18M | 10,240.54%3.83M | -43.27%5.12M | 2,823.53%1.99M | -64.94%2.92M | -14.95%182K | -91.42%37K | -24.73%9.03M | 68K |
| Operating revenue | -161.06%-1.78M | 2,744.51%5.18M | 10,240.54%3.83M | -43.27%5.12M | 2,823.53%1.99M | -64.94%2.92M | -14.95%182K | -91.42%37K | -24.73%9.03M | --68K |
| Cost of revenue | 61.11%435K | 298.53%542K | 1,573.53%1.14M | 2.90%746K | 338.71%272K | 62.65%270K | -37.90%136K | -75.54%68K | 725K | 62K |
| Gross profit | -183.72%-2.22M | 9,976.09%4.64M | 8,770.97%2.69M | -47.30%4.38M | 28,500.00%1.72M | -67.53%2.65M | 1,020.00%46K | -120.26%-31K | -30.78%8.31M | 6K |
| Operating expense | -30.40%18.49M | 70.13%19.84M | 201.60%21.29M | 128.36%67.6M | 258.94%22.32M | 296.18%26.56M | 27.93%11.66M | -6.68%7.06M | -31.01%29.6M | -26.60%6.22M |
| Selling and administrative expenses | -19.80%16.08M | 178.29%16.52M | 278.31%16.34M | 171.79%47.31M | 432.93%17M | 410.93%20.05M | 14.77%5.94M | -15.61%4.32M | -35.49%17.41M | -37.63%3.19M |
| Research and development costs | -63.06%2.41M | -42.03%3.32M | 80.65%4.95M | 66.38%20.3M | 75.69%5.32M | 134.17%6.51M | 45.19%5.73M | 12.02%2.74M | -23.42%12.2M | -9.80%3.03M |
| Operating profit | 13.43%-20.7M | -30.91%-15.21M | -162.36%-18.6M | -196.87%-63.22M | -231.65%-20.6M | -1,751.73%-23.92M | -27.35%-11.62M | 4.33%-7.09M | 31.10%-21.3M | 26.67%-6.21M |
| Net non-operating interest income expense | -158.08%-2.16M | -415.50%-1.98M | -444.20%-1.72M | 27.95%-1.22M | -629.02%-1.51M | -1,346.27%-835K | 159.85%626K | 147.17%500K | 59.35%-1.7M | 126.73%286K |
| Non-operating interest income | -73.11%221K | -37.22%393K | 19.60%598K | 475.63%2.74M | 176.92%792K | 455.41%822K | 3,030.00%626K | 2,172.73%500K | 286.99%476K | 959.26%286K |
| Non-operating interest expense | 43.39%2.38M | --2.37M | --2.32M | 82.41%3.96M | --2.31M | 1,945.68%1.66M | --0 | --0 | -49.43%2.17M | --0 |
| Other net income (expense) | 98.00%-1K | -5K | -11K | -70.64%-2.55M | -35,642.86%-2.5M | 96.51%-50K | -1.5M | -7K | ||
| Special income (charges) | ---- | ---- | ---- | -76.55%-2.54M | ---- | ---- | ---- | ---- | ---1.44M | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.44M | --0 |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---2.54M | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non- operating income (expenses) | 98.00%-1K | ---5K | ---11K | 75.86%-14K | 600.00%35K | -1,100.00%-50K | ---- | ---- | ---58K | ---7K |
| Income before tax | 7.83%-22.86M | -56.38%-17.19M | -208.56%-20.33M | -173.59%-67M | -314.94%-24.61M | -29,981.93%-24.8M | -8.08%-10.99M | 22.21%-6.59M | 30.20%-24.49M | 37.82%-5.93M |
| Income tax | ||||||||||
| Net income | 7.83%-22.86M | -56.38%-17.19M | -208.56%-20.33M | -173.59%-67M | -314.94%-24.61M | -29,981.93%-24.8M | -8.08%-10.99M | 22.21%-6.59M | 30.20%-24.49M | 37.82%-5.93M |
| Net income continuous Operations | 7.83%-22.86M | -56.38%-17.19M | -208.56%-20.33M | -173.59%-67M | -314.94%-24.61M | -29,981.93%-24.8M | -8.08%-10.99M | 22.21%-6.59M | 30.20%-24.49M | 37.82%-5.93M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 7.83%-22.86M | -56.38%-17.19M | -208.56%-20.33M | -173.59%-67M | -314.94%-24.61M | -29,981.93%-24.8M | -8.08%-10.99M | 22.21%-6.59M | 30.20%-24.49M | 37.82%-5.93M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 7.83%-22.86M | -56.38%-17.19M | -208.56%-20.33M | -173.59%-67M | -314.94%-24.61M | -29,981.93%-24.8M | -8.08%-10.99M | 22.21%-6.59M | 30.20%-24.49M | 37.82%-5.93M |
| Basic earnings per share | 9.26%-0.49 | -54.17%-0.37 | -193.33%-0.44 | -105.56%-1.48 | -285.71%-0.54 | -26,326.32%-0.54 | 35.14%-0.24 | 51.61%-0.15 | 44.62%-0.72 | 60.00%-0.14 |
| Diluted earnings per share | 9.26%-0.49 | -54.17%-0.37 | -193.33%-0.44 | -105.56%-1.48 | -285.71%-0.54 | -26,339.07%-0.54 | 35.14%-0.24 | 51.61%-0.15 | 44.62%-0.72 | 60.00%-0.14 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.